Trial ID or NCT#

NCT00507702

Status

not recruiting iconNOT RECRUITING

Purpose

To identify unique blood markers in cancer patients so that we can identify patients with evidence of pre-existing immunity who may be a responder to immunotherapy.

Official Title

Identification of Key Blood Molecular Markers for Immunotherapy

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Jeffrey Norton, MD
Jeffrey Norton, MD
Surgical oncologist
Robert L. and Mary Ellenburg Professor of Surgery

Contact us to find out if this trial is right for you.

CONTACT

Kangla Tsung
(650) 725-8198